Global Rheumatoid Arthritis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147483
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities.

Scope of the Report:

This report focuses on the Rheumatoid Arthritis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Rheumatoid Arthritis Drugs is expected to grow at a CAGR of roughly 4.4% over the next five years, will reach 27400 million US$ in 2023, from 21200 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AbbVie

Boehringer Ingelheim

Novartis

Regeneron

Pfizer

Bristol-Myers Squibb

Roche

UCB

Johnson & Johnson

Amgen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Prescription

Over-the-Counter (OTC)

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Rheumatoid Arthritis Drugs market.

Chapter 1, to describe Rheumatoid Arthritis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Rheumatoid Arthritis Drugs, with sales, revenue, and price of Rheumatoid Arthritis Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Rheumatoid Arthritis Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Rheumatoid Arthritis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Rheumatoid Arthritis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Rheumatoid Arthritis Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Prescription

1.2.2 Over-the-Counter (OTC)

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Rheumatoid Arthritis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim

2.2.1 Business Overview

2.2.2 Rheumatoid Arthritis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Rheumatoid Arthritis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Regeneron

2.4.1 Business Overview

2.4.2 Rheumatoid Arthritis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Regeneron Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Rheumatoid Arthritis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bristol-Myers Squibb

2.6.1 Business Overview

2.6.2 Rheumatoid Arthritis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Roche

2.7.1 Business Overview

2.7.2 Rheumatoid Arthritis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Roche Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 UCB

2.8.1 Business Overview

2.8.2 Rheumatoid Arthritis Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 UCB Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Johnson & Johnson

2.9.1 Business Overview

2.9.2 Rheumatoid Arthritis Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Johnson & Johnson Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Amgen

2.10.1 Business Overview

2.10.2 Rheumatoid Arthritis Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Amgen Rheumatoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Rheumatoid Arthritis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Rheumatoid Arthritis Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Rheumatoid Arthritis Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Rheumatoid Arthritis Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Rheumatoid Arthritis Drugs Market Analysis by Regions

4.1 Global Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Rheumatoid Arthritis Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

4.5 South America Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

5 North America Rheumatoid Arthritis Drugs by Countries

5.1 North America Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Rheumatoid Arthritis Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Rheumatoid Arthritis Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

6 Europe Rheumatoid Arthritis Drugs by Countries

6.1 Europe Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Rheumatoid Arthritis Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Rheumatoid Arthritis Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

6.3 UK Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

6.4 France Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Rheumatoid Arthritis Drugs by Countries

7.1 Asia-Pacific Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Rheumatoid Arthritis Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Rheumatoid Arthritis Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

7.5 India Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

8 South America Rheumatoid Arthritis Drugs by Countries

8.1 South America Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Rheumatoid Arthritis Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Rheumatoid Arthritis Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Rheumatoid Arthritis Drugs by Countries

9.1 Middle East and Africa Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Rheumatoid Arthritis Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Rheumatoid Arthritis Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Rheumatoid Arthritis Drugs Sales and Growth Rate (2013-2018)

10 Global Rheumatoid Arthritis Drugs Market Segment by Type

10.1 Global Rheumatoid Arthritis Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Rheumatoid Arthritis Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Type (2013-2018)

10.2 Prescription Sales Growth and Price

10.2.1 Global Prescription Sales Growth (2013-2018)

10.2.2 Global Prescription Price (2013-2018)

10.3 Over-the-Counter (OTC) Sales Growth and Price

10.3.1 Global Over-the-Counter (OTC) Sales Growth (2013-2018)

10.3.2 Global Over-the-Counter (OTC) Price (2013-2018)

11 Global Rheumatoid Arthritis Drugs Market Segment by Application

11.1 Global Rheumatoid Arthritis Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.1 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Rheumatoid Arthritis Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.2.2 Europe Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.2.4 South America Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Rheumatoid Arthritis Drugs Market Forecast (2018-2023)

12.3 Rheumatoid Arthritis Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Rheumatoid Arthritis Drugs Market Share Forecast by Type (2018-2023)

12.4 Rheumatoid Arthritis Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Rheumatoid Arthritis Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Rheumatoid Arthritis Drugs Picture

Table Product Specifications of Rheumatoid Arthritis Drugs

Figure Global Sales Market Share of Rheumatoid Arthritis Drugs by Types

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery